Naturhouse Health SA

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: ES0105043006
EUR
2.49
-0.04 (-1.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 60.39%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 22.81

 
3

Poor long term growth as Net Sales has grown by an annual rate of -6.11% and Operating profit at -8.51% over the last 5 years

 
4

With ROE of 65.53%, it has a Fair valuation with a 5.25 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 152 Million (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

798.42%

stock-summary
Debt Equity

-0.79

stock-summary
Return on Equity

65.53%

stock-summary
Price to Book

5.88

Revenue and Profits:
Net Sales:
30 Million
(Quarterly Results - Mar 2022)
Net Profit:
7 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.88%
0%
23.88%
6 Months
31.05%
0%
31.05%
1 Year
42.29%
0%
42.29%
2 Years
58.1%
0%
58.1%
3 Years
23.27%
0%
23.27%
4 Years
33.51%
0%
33.51%
5 Years
36.81%
0%
36.81%

Naturhouse Health SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-6.11%
EBIT Growth (5y)
-8.51%
EBIT to Interest (avg)
22.81
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
2.35
Tax Ratio
27.95%
Dividend Payout Ratio
49.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
106.85%
ROE (avg)
60.39%

Valuation key factors

Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
5.25
EV to EBIT
5.19
EV to EBITDA
4.67
EV to Capital Employed
21.47
EV to Sales
1.55
PEG Ratio
0.09
Dividend Yield
884.96%
ROCE (Latest)
413.80%
ROE (Latest)
65.53%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'22 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2022 is 107.53% vs -12.57% in Mar 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2022 is 83.33% vs 50.00% in Mar 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'22",
        "Mar'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.30",
          "val2": "14.60",
          "chgp": "107.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.20",
          "val2": "5.60",
          "chgp": "64.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.60",
          "val2": "3.60",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "265.10%",
          "val2": "335.50%",
          "chgp": "-7.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.98% vs -3.82% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -11.61% vs 16.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "49.40",
          "val2": "50.40",
          "chgp": "-1.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.40",
          "val2": "18.60",
          "chgp": "-17.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "9.90",
          "val2": "11.20",
          "chgp": "-11.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "272.50%",
          "val2": "323.10%",
          "chgp": "-5.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'22 - YoYstock-summary

Mar'22
Mar'21
Change(%)
Net Sales
30.30
14.60
107.53%
Operating Profit (PBDIT) excl Other Income
9.20
5.60
64.29%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.60
3.60
83.33%
Operating Profit Margin (Excl OI)
265.10%
335.50%
-7.04%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2022 is 107.53% vs -12.57% in Mar 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2022 is 83.33% vs 50.00% in Mar 2021

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
49.40
50.40
-1.98%
Operating Profit (PBDIT) excl Other Income
15.40
18.60
-17.20%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.90
11.20
-11.61%
Operating Profit Margin (Excl OI)
272.50%
323.10%
-5.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -1.98% vs -3.82% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -11.61% vs 16.67% in Dec 2023

stock-summaryCompany CV
About Naturhouse Health SA stock-summary
stock-summary
Naturhouse Health SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available